Blog

Ideas, analysis and perspectives on leadership, communication and business results.

How to Deliver an Executive Presentation with Impact and Leadership

Learn to design clear and assertive executive presentations, avoiding common mistakes and using them as leadership auditions to advance your career.

The Trifecta of Effective Communication

Discover how to combine kindness, assertiveness, and empathy to communicate with impact, lead difficult conversations, and persuade without losing your essence.

The 4 Types of Presentations According to Your Context

Present better in any context: discover how to combine empathetic and assertive communication in 4 types of presentations to plan your message and.

Scientifically Proven Resources to Get Applause in Your Presentations

Discover what science says about applause in public presentations and how certain rhetorical devices can increase connection with your audience.

The 2 Criteria Necessary for Education to Exist

Education is not having all the information or using AI, but persuading. Discover why no chatbot can replace what you do when teaching.

What FDA Warning Letters Are and Why You Should Know About Them

Miraculous supplements? Be careful. The FDA publishes a list of companies selling illegal products. Check the Advisory Letters and avoid scams.

The Oncology Radar: Summary of Latest FDA Approvals (November-December 2025)

Summary of FDA oncology approvals (Nov-Dec 2025): Updates in amyloidosis, lymphoma and leukemia. Stay up to date with new treatments.

A New Cellular Opportunity: FDA Approves Breyanzi for Marginal Zone Lymphoma

FDA approves Breyanzi (CAR-T) for relapsed marginal zone lymphoma. 84% response rate. New hope for adult patients.

How Artificial Intelligence is Revolutionizing Drug Development

The FDA drives the use of Artificial Intelligence in drug development. Learn how CDER regulates this innovation to create safe medicines.

Breakthrough in Gastric Cancer: FDA Approves Durvalumab (Imfinzi) for Resectable Stages

FDA approves durvalumab (Imfinzi) + chemotherapy for resectable gastric cancer. Improves survival and complete response. Details here.

Hope Against Leukemia: FDA Grants Traditional Approval to Pirtobrutinib (Jaypirca)

FDA approves pirtobrutinib (Jaypirca) for CLL and SLL in adults. Learn about the benefits, safety, and BRUIN study data in this article.

Accelerated Approvals in Cancer: How They Work and Why They Matter

Accelerated approvals: early access to cancer therapies based on initial evidence while confirmatory studies are completed.

← Previous2 / 30Next →